Loading...
Controlled trials assessing recurrence rates of nonmelanoma skin cancer (NMSC) are few and far between. In this prospective cohort study conducted at a Veterans Affairs hospital, 495 patients with 611 primary NMSCs treated over a 2-year period with electrodesiccation and curettage (ED&C), excision, or Mohs surgery were followed for a median of 6.6 years. The chart review data was validated by examination of a subset of patients, and similar recurrence data were found.
Basal cell carcinomas (BCCs) made up 87% of the tumors treated by ED&C, 66% of tumors treated by excision, and 75% of tumors treated by Mohs. A much higher percentage of the tumors treated by ED&C were located on the trunk and extremities (64%) compared with those treated by ex…